Global Pharmatech, Inc.
Global Pharmatech, Inc. (GBLP) Revenue
Annual & quarterly revenue history · segment & region breakdown
GBLP · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsGlobal Pharmatech, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Global Pharmatech, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Global Pharmatech, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Global Pharmatech, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GBLP revenue · 4 questionsGBLP's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Global Pharmatech, Inc. SEC filings · GAAP · Global Pharmatech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026